Prime Medicine, Inc.
PRME- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001894562
No open-market purchases or sales by Prime Medicine, Inc. insiders were filed in the last 90 days; 187 institutions reported holding it in 13F filings for Q2 2026, worth $393.5M in total; ARK Invest is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Prime Medicine, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 115 | 122 | +7 |
| Shares | 66.7M | 68.9M | +2.23M (+3.3%) |
| Value | $466.6M | $354.0M | −$112.6M (−24.1%) |
New holders (26)
Institutions that held Prime Medicine, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (19)
Institutions that held Prime Medicine, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Renaissance Technologies LLC | 362,400 | $2.54M |
| Schonfeld Strategic Advisors LLC | 330,500 | $2.31M |
| Deep Track Capital, LP | 303,716 | $2.13M |
| TrueMark Investments, LLC | 85,183 | $596.3K |
| Tudor Investment Corp Et Al | 61,295 | $429.1K |
| Bank of Montreal | 46,637 | $327.4K |
| HRT Financial LP | 41,000 | $287.0K |
| Cinctive Capital Management LP | 33,033 | $231.2K |
| Brandywine Managers, LLC | 32,977 | $230.8K |
| Verition Fund Management LLC | 29,515 | $206.6K |
| Levin Capital Strategies, L.P. | 26,500 | $185.5K |
| American International Group, Inc. | 19,496 | $136.5K |
| Red Lighthouse Investment Management, LLC | 14,950 | $104.7K |
| Walleye Capital LLC | 10,443 | $73.1K |
| EntryPoint Capital, LLC | 7,997 | $56.0K |
| Simplex Trading, LLC | 4,837 | $33.0K |
| Federated Hermes, Inc. | 3,576 | $25.0K |
| Metropolitan Life Insurance Co | 2,203 | $15.4K |
| Riggs Asset Managment Co. Inc. | 36 | $252 |